Physical Activity and Nutrition in Cancer Survivors

April 1, 2024 updated by: Lei Liu, West China Hospital

Joint Association of Physical Activity and Dietary Quality With Survival Among US Cancer Survivors

This study aims to investigate the independent and combined associations between physical activity and nutrition condition with mortality among cancer survivors.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

3100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

The data of this observational cohort study were extracted from six consecutive cycles of the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey (NHANES): including waves of 2007-2008, 2009-2010, 2011-2012, 2013-2014, 2015-2016, and 2017-2018. The NHANES database systematically gathered nationally representative health-related data on non-institutionalized general US civilians, utilizing a stratified, multistage probability sampling design.

Description

Inclusion Criteria:

  • Participants with history of cancers were included

Exclusion Criteria:

  • Participants with missing cancer investigation, dietary recall, and incomplete follow-up information were excluded from this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All-cause mortality
Time Frame: Jan 1 2017 to Dec 31 2019
To evaluate the overall survival of cancer survivors
Jan 1 2017 to Dec 31 2019
Cause-specific mortality
Time Frame: Jan 1 2017 to Dec 31 2019
To evaluate the cancer specific survival of cancer survivors
Jan 1 2017 to Dec 31 2019

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

West China Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2007

Primary Completion (Actual)

December 31, 2018

Study Completion (Actual)

December 31, 2018

Study Registration Dates

First Submitted

April 1, 2024

First Submitted That Met QC Criteria

April 1, 2024

First Posted (Actual)

April 5, 2024

Study Record Updates

Last Update Posted (Actual)

April 5, 2024

Last Update Submitted That Met QC Criteria

April 1, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • #2005-06; #2011-17; #2018-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no plan to make individual participant data (IPD) available to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on physical activity and nutrition assessment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe